Sangamo Therapeutics (SGMOQ) Return on Equity [ROE] (2009 - 2025)
Sangamo Therapeutics' Return on Equity [ROE] came in at -2891.84% for FY2025, down 2706.44 percentage points from -185.39% in FY2024.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Return on Equity [ROE] (2009 - 2025) Analysis & Trends
Going back to FY2010, Sangamo Therapeutics' Return on Equity [ROE] data covers 16 years.
- Return on Equity [ROE] has declined in each of the last six years, with a five-year change of -2865.79 percentage points (FY2020 to FY2025).
- The FY2025 figure represents the lowest annual Return on Equity [ROE] in data going back to FY2010.
- Per Business Quant, earlier years put Return on Equity [ROE] at -185.39% in FY2024 (-48.92 pp), -136.47% in FY2023 (-79.10 pp), -57.37% in FY2022 (-16.51 pp) and -40.86% in FY2021 (-14.82 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -842.79% |
| Jun 30, 2025 | -516.62% |
| Mar 31, 2025 | -574.14% |
| Dec 31, 2024 | -316.43% |
| Sep 30, 2024 | -429.26% |
| Jun 30, 2024 | -621.18% |
| Mar 31, 2024 | -470.04% |
| Dec 31, 2023 | -236.75% |
| Sep 30, 2023 | -135.40% |
| Jun 30, 2023 | -69.74% |
| Mar 31, 2023 | -40.33% |
| Dec 31, 2022 | -63.66% |
| Sep 30, 2022 | -56.68% |
| Jun 30, 2022 | -52.80% |
| Mar 31, 2022 | -49.68% |
| Dec 31, 2021 | -45.64% |
| Sep 30, 2021 | -42.63% |
| Jun 30, 2021 | -29.58% |
| Mar 31, 2021 | -25.67% |
| Dec 31, 2020 | -23.79% |
API Access
Sangamo Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();